Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
The Annual THI Perfusion Conference will be held June 5-6, 2020 at Texas Heart Institute. The agenda for this year’s conference will include case reviews and discussion about the latest trends in the industry. Conference participants will earn 16.2 CAT I Continuing Education Credits (CEUs) from the American Board of Cardiovascular Perfusion (ABCP). Funds raised...
Find out more »